Home Cost of illness of diabetes mellitus in Indonesia: a systematic review
Article
Licensed
Unlicensed Requires Authentication

Cost of illness of diabetes mellitus in Indonesia: a systematic review

  • Yohana Febriani Putri Peu Patty , Mufarrihah and Yunita Nita EMAIL logo
Published/Copyright: June 25, 2021

Abstract

Objectives

Diabetes Mellitus (DM) is a group of insulin metabolism disorder that affects the socio-economic conditions of the community. The cost of treating diabetes in 2019 was USD 760 billion and by 2045 there are predicted to be 700 million people living with diabetes. The purpose of this systematic review was to provide an overview of the economic burden caused by Diabetes Mellitus for the government, health care providers, and for the community.

Methods

This systematic review was carried out by considering the related studies about the cost of illness, evaluation of disease costs, or therapeutic costs for various types of diabetes mellitus that were published in both English and Indonesian. The search engines PUBMED, DOAJ, SCOPUS, SCIENCE DIRECT, and GOOGLE SCHOLAR were used without date published restrictions.

Results

A systematic search identifies 18 eligible studies conducted in various regions in Indonesia. The study was retrospective with variation in their perspectives and methods to estimate the diabetes cost. Drug cost was the major contributor to direct medical cost followed by complications cost while other cost was affected by transportation cost, productivity losses, and time spent by family accompanying patients.

Conclusions

Diabetes mellitus creates a significant financial burden and affects the health care system as well as the individual and society as a whole. Research about the cost of diabetes in the future should be carried out on a large scale in order to get a more specific cost estimation.


Corresponding author: Yunita Nita, Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Kampus C, UNAIR, Mulyorejo, Surabaya, 60115, Indonesia, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: There is no informed consent in this study because this is a systematic review.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review because this is a systematic review.

References

1. Wells, B, Dipiro, C, Dipiro, J, Schwinghammer, T. Pharmacotherapy handbook, 7th ed. New York: The McGraw-Hill Companies; 2009.Search in Google Scholar

2. World Health Organization. Classification of diabetes mellitus 2019. Geneva: World Health Organization; 2019:5–27 pp.Search in Google Scholar

3. Saeedi, P, Petersohn, I, Salpea, P, Malanda, B, Karuranga, S, Unwin, N, et al.. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas. Diabetes Res Clin Pract 2019;157:107843. https://doi.org/10.1016/j.diabres.2019.107843.Search in Google Scholar

4. International Diabetes Federation. IDF diabetes atlas ninth edition. International Diabetes Federation; 2019:6–94 pp.Search in Google Scholar

5. Ng, CS, Lee, JY, Toh, MP, Ko, Y. Cost-of-illness studies of diabetes mellitus: a systematic review. Diabetes Res Clin Pract 2014;105:151–63. https://doi.org/10.1016/j.diabres.2014.03.020.Search in Google Scholar

6. Kementerian Kesehatan Republik Indonesia. Baseline health research 2018. Jakarta: Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan; 2019.Search in Google Scholar

7. Afroz, A, Alramadan, MJ, Hossain, MN, Romero, L, Alam, K, Magliano, DJ, et al.. Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review. BMC Health Serv Res 2018;18:972. https://doi.org/10.1186/s12913-018-3772-8.Search in Google Scholar

8. Andayani, TM. Cost analysis of diabetes mellitus therapy in Dr. Sardjito Hospital Yogyakarta. Maj Farm Indonesia 2006;17.Search in Google Scholar

9. Andayani, TM, Imaningsih, I. Cost analysis of antidiabetic drugs for diabetes mellitus outpatient in Kodya Yogyakarta Hospital. Malays J Pharmaceut Sci 2007;5:19–23.Search in Google Scholar

10. Dyah, RI, Wahyono, D, Andayani, TM. Cost analysis of therapy diabetes mellitus hospitallized patient. J Manaj Dan Pelayanan Farm 2014;4:55–62.Search in Google Scholar

11. Fitri, E, Andayani, TM, Suparniati, E. Cost analysis of diabetes mellitus. J Manaj Dan Pelayanan Farm 2015;5.Search in Google Scholar

12. Yuniarti, E, Amalia, A, Handayani, TM. Cost analysis of diabetes mellitus patients in the national health insurance at PKU Muhammadiyah Hospital – comparison with INA CBGS rates. J Kebijakan Kesehat Indonesia 2015;4:97–103.Search in Google Scholar

13. Amalia, Andayani, TM, Yuniarti, E. Relationship of diabetes mellitus complication towards cost of theraphy. J Manaj Dan Pelayanan Farm 2015;5:159–70.Search in Google Scholar

14. Baroroh, F, Solikah, WY, Aina Urfiyya, Q. Cost analysis of type 2 diabetes mellitus in PKU Muhammadiyah Bantul Yogyakarta Hospital. J Farm Sains Dan Prakt 2016;1:11–21.Search in Google Scholar

15. Mursalin, SP. Analisis Estimasi Biaya Langsung Medis Penderita Rawat Jalan Diabetes Mellitus Tipe 2 di RSUD Dr. Abdul Aziz Singkawang Tahun 2013. J Ekon Kesehat Indonesia 2016;1.10.7454/eki.v1i2.1770Search in Google Scholar

16. Sutrisno, D, Lestari, D, Dewi, R, Yuliawati. Analisis Biaya Penyakit Diabetes Melitus Tipe II Pasien BPJS Di Bangsal Penyakit Dalam RSUD Raden Mattaher Jambi Tahun. Ris Inf Kesehat 2017;6:64–70.Search in Google Scholar

17. Hartanto, D, Mulyani, T. Gambaran Biaya Pasien Diabetes Melitus Tipe 2 Dengan Terapi Antidiabetik Oral Di RSUD Ulin Banjarmasin. J Ilm Ibnu Sina 2017;2:109–16.Search in Google Scholar

18. Sari, LS. Cost of illness and quality of life analysis of type 2 diabetes mellitus patients with heart disease. J Ekon Kesehat Indonesia 2017;1.Search in Google Scholar

19. Sholih, MG, Muhtadi, A, Saidah, S. Cost of illness analysis of insulin and insulin-metformin combination usage towards diabetes mellitus type 2 patients at hospital in Bandung. Indones J Clin Pharm 2018;7:10–8. https://doi.org/10.15416/ijcp.2018.7.1.10.Search in Google Scholar

20. Zufry, H. The duration of care and direct cost of amputate diabetic foot patient in RS Dr. Zainoel Abidin Banda Aceh: pre-eliminary study. Averrous 2018;4:81–92. https://doi.org/10.29103/averrous.v4i1.807.Search in Google Scholar

21. Ambianti, N, Andayani, TM, Sulistiawaty, E. Cost analysis of diabetes mellitus disease as considerations in health funding planning. J Farm Galenika 2019;5:73–83.10.22487/j24428744.2019.v5.i1.12071Search in Google Scholar

22. Sasongko, MB, Wardhana, FS, Febryanto, GA, Agni, AN, Supanji, S, Indrayanti, SR, et al.. The estimated healthcare cost of diabetic retinopathy in Indonesia and its projection for 2025. Br J Ophthalmol 2019;104:487–92. https://doi.org/10.1136/bjophthalmol-2019-313997.Search in Google Scholar

23. Anggriani, Y, Rianti, A, Pratiwi, AN, Khairani, S. Treatment cost evaluation of type 2 diabetes mellitus outpatient patients receiving insulin therapy at RSUP X Jakarta within January 2016–December 2017 period. Pharmaceut J Indonesia 2019;4:91–7. https://doi.org/10.36387/jiis.v4i1.212.Search in Google Scholar

24. Ratnasari, PMD, Andayani, TM, Endarti, D. Analisis Perbedaan Biaya Medik Langsung Pasien Diabetes Melitus Tipe 2. J Insan Farm Indonesia 2019;2:156–65. https://doi.org/10.36387/jifi.v2i2.414.Search in Google Scholar

25. Putri, REK, Darmawan, E, Perwitasari, DA. Cost of illness type 2 diabetes mellitus and its complications in national health insurance at outpatient Condong Catur Hospital Yogyakarta. J Farm Indonesia 2019;16:89–101. https://doi.org/10.23917/pharmacon.v16i2.8915.Search in Google Scholar

26. Hassard, J, Teoh, KR, Visockaite, G, Dewe, P, Cox, T. The cost of work-related stress to society: a systematic review. J Occup Health Psychol 2018;23:1. https://doi.org/10.1037/ocp0000069.Search in Google Scholar

27. OECD. Inflation (CPI) [Internet]. Available from: https://data.oecd.org/price/inflation-cpi.htm [Accessed 23 Sep 2020].Search in Google Scholar

28. OECD. Purchasing power parities (PPP) [Internet]; 2019. Available from: https://data.oecd.org/conversion/purchasing-power-parities-ppp.htm [Accessed 23 Sep 2020].Search in Google Scholar

29. Liberati, A, Altman, DG, Tetzlaff, J, Mulrow, C, Gøtzsche, PC, Ioannidis, JP, et al.. The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151:65–94. https://doi.org/10.7326/0003-4819-151-4-200908180-00136.Search in Google Scholar

30. Badan Penyelenggara Jaminan Sosial. Petunjuk Teknis Verifikasi Klaim. Jakarta: Direktorat Pelayanan BPJS Kesehatan; 2014.Search in Google Scholar

31. Le, C, Lin, L, Jun, D, Jianhui, H, Keying, Z, Wenlong, C, et al.. The economic burden of type 2 diabetes mellitus in rural southwest China. Int J Cardiol 2013;165:273–7. https://doi.org/10.1016/j.ijcard.2011.08.039.Search in Google Scholar

32. Fu, AZ, Qiu, Y, Radican, L, Wells, BJ. Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care 2009;32:2187–92. https://doi.org/10.2337/dc09-1128.Search in Google Scholar

33. Bommer, C, Heesemann, E, Sagalova, V, Manne-Goehler, J, Atun, R, Bärnighausen, T, et al.. The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study. Lancet Diabetes Endocrinol 2017;5:423–30. https://doi.org/10.1016/s2213-8587(17)30097-9.Search in Google Scholar

34. Zhang, Y, Dall, TM, Mann, SE, Chen, Y, Martin, J, Moore, V, et al.. The economic costs of undiagnosed diabetes. Popul Health Manag 2009;12:95–101. https://doi.org/10.1089/pop.2009.12202.Search in Google Scholar

35. Javanbakht, M, Baradaran, HR, Mashayekhi, A, Haghdoost, AA, Khamseh, ME, Kharazmi, E, et al.. Cost-of-illness analysis of type 2 diabetes mellitus in Iran. PloS One 2011;6:e26864.10.1371/journal.pone.0026864Search in Google Scholar PubMed PubMed Central

36. Cook, CB, Naylor, DB, Hentz, JG, Miller, WJ, Tsui, C, Ziemer, DC, et al.. Disparities in diabetes-related hospitalizations: relationship of age, sex, and race/ethnicity with hospital discharges, lengths of stay, and direct inpatient charges. Ethn Dis 2006;16:126.Search in Google Scholar

37. Wu, H, Eggleston, KN, Zhong, J, Hu, R, Wang, C, Xie, K, et al.. How do type 2 diabetes mellitus (T2DM)-related complications and socioeconomic factors impact direct medical costs? a cross-sectional study in rural Southeast China. BMJ open 2018;8:e020647. https://doi.org/10.1136/bmjopen-2017-020647.Search in Google Scholar

38. Liu, Z, Fu, C, Wang, W, Xu, B. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients-a cross-sectional hospital based survey in urban China. Health Qual Life Outcome 2010;8:62. https://doi.org/10.1186/1477-7525-8-62.Search in Google Scholar

39. Liebl, A, Khunti, K, Orozco-Beltran, D, Yale, J-F. Health economic evaluation of type 2 diabetes mellitus: a clinical practice focused review. Clin Med Insights Endocrinol Diabetes 2015;8:13–9.10.4137/CMED.S20906Search in Google Scholar PubMed PubMed Central

40. Pham, HTK, Kieu, TTM, Duong, TD, Van Nguyen, KD, Tran, NQ, Tran, TH, et al.. Direct medical costs of diabetes and its complications in Vietnam: a national health insurance database study. Diabetes Res Clin Pract 2020;162:108051.10.1016/j.diabres.2020.108051Search in Google Scholar PubMed

41. Kumar, A, Nagpal, J, Bhartia, A. Direct cost of ambulatory care of type 2 diabetes in the middle and high income group populace of Delhi: the dedicom survey. JAPI 2008;56:667–74.Search in Google Scholar

42. Tharkar, S, Devarajan, A, Kumpatla, S, Viswanathan, V. The socioeconomics of diabetes from a developing country: a population based cost of illness study. Diabetes Res Clin Pract 2010;89:334–40. https://doi.org/10.1016/j.diabres.2010.05.009.Search in Google Scholar

43. Chaikledkaew, U, Pongchareonsuk, P, Chaiyakunapruk, N, Ongphiphadhanakul, B. Factors affecting health‐care costs and hospitalizations among diabetic patients in Thai public hospitals. Value Health 2008;11:S69–74. https://doi.org/10.1111/j.1524-4733.2008.00369.x.Search in Google Scholar

44. Wang, W, McGreevey, WP, Fu, C, Zhan, S, Luan, R, Chen, W, et al.. Type 2 diabetes mellitus in China: a preventable economic burden. Am J Manag Care 2009;15:593–601.Search in Google Scholar

45. Litwak, L, Goh, S-Y, Hussein, Z, Malek, R, Prusty, V, Khamseh, ME. Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline Characteristics in the multinational achieve study. Diabetol Metab Syndrome 2013;5:57. https://doi.org/10.1186/1758-5996-5-57.Search in Google Scholar

46. Delamater, AM. Improving patient adherence. Clin Diabetes 2006;24:71–7. https://doi.org/10.2337/diaclin.24.2.71.Search in Google Scholar

47. Peyrot, M, Rubin, RR, Lauritzen, T, Skovlund, SE, Snoek, FJ, Matthews, DR, et al.. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28:2673–9. https://doi.org/10.2337/diacare.28.11.2673.Search in Google Scholar

48. Top, M, Aslan, H, Akyürek, ÇE, Aslan, EÇ. Costs analysis of diabetes mellitus: a study based on hospital invoices and diagnosis related groups. Health Pol Technol 2020;9:23–31. https://doi.org/10.1016/j.hlpt.2020.01.005.Search in Google Scholar

49. Moucheraud, C, Lenz, C, Latkovic, M, Wirtz, VJ. The costs of diabetes treatment in low-and middle-income countries: a systematic review. BMJ Glob Health 2019;4. https://doi.org/10.1136/bmjgh-2018-001258.Search in Google Scholar

50. Lohani, S. Economic burden of diabetic patients in private and public hospitals. Value Health 2014;17:A246. https://doi.org/10.1016/j.jval.2014.03.1436.Search in Google Scholar

51. Happy, A. The implementation of INA-CBGs system impact on financial performance of public hospital, the Indonesia case: a systematic review. KnE Life Sci 2018:1–16. https://doi.org/10.18502/kls.v4i9.3553.Search in Google Scholar

52. Sari, RP. Perbandingan biaya riil dengan tarif paket ina-cbg’s dan analisis faktor yang mempengaruhi biaya riil pada pasien diabetes melitus rawat inap jamkesmas di RSUP Dr. Sardjito Yogyakarta. Jurnal Ilm Bisnis Dan Keuang 2016;4.Search in Google Scholar


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jbcpp-2020-0502).


Received: 2020-12-09
Accepted: 2021-02-03
Published Online: 2021-06-25

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Cost of illness of diabetes mellitus in Indonesia: a systematic review
  4. Social media health interventions to improve diabetes mellitus patient outcome: a systematic review
  5. Developing pharmacokinetics–pharmacodynamics model of valproic acid syrup based on prediction of population pharmacokinetics parameter and seizure frequency in Indonesian pediatric epilepsy outpatients
  6. Acetylcholinesterase inhibitory activity of extract and fractions from the root of Rauvolfia serpentina(L.) Bth.ex Kurz
  7. Green tea and its active compound epigallocathechin-3-gallate (EGCG) inhibit neuronal apoptosis in a middle cerebral artery occlusion (MCAO) model
  8. The effects of quercetin on nicotine-induced reward effects in mice
  9. Resveratrol ameliorates physical and psychological stress-induced depressive-like behavior
  10. Translation and cross-cultural adaption of an instrument measuring patient’s well-being under treatment for schizophrenia
  11. Quercetin promotes behavioral recovery and biomolecular changes of melanocortin-4 receptor in mice with ischemic stroke
  12. Knowledge and attitudes of healthcare professionals on prescribing errors
  13. Inhibition of Ras and STAT3 activity of 4-(tert-butyl)-N-carbamoylbenzamide as antiproliferative agent in HER2-expressing breast cancer cells
  14. Predicting the molecular mechanism of glucosamine in accelerating bone defect repair by stimulating osteogenic proteins
  15. Larvicidal toxicity and parasporal inclusion of native Bacillus thuringiensis BK5.2 against Aedes aegypti
  16. Synthesis, ADMET predictions, molecular docking studies, and in-vitro anticancer activity of some benzoxazines against A549 human lung cancer cells
  17. Thymoquinone and its derivatives against breast cancer with HER2 positive: in silico studies of ADMET, docking and QSPR
  18. Assessment of patient understanding of their conventional cardiac medicines and herbal prepared/derived products: preliminary survey and interviews with selected community-dwelling elderly patients in the Philippines
  19. The development and validation of the health belief model questionnaire for measuring factors affecting adherence in the elderly with hypertension
  20. Analysis of the side effect of QTc interval prolongation in the bedaquiline regimen in drug resistant tuberculosis patients
  21. Shallot skin profilling, computational evaluation of physicochemical properties, ADMET, and molecular docking of its components against P2Y12 receptor
  22. Analysis of HMGB-1 level before and after providing atorvastatin standard therapy in coronary artery disease patients with type-2 diabetes mellitus compared to without type-2 diabetes mellitus
  23. Analysis of matrix metalloproteinase-9 levels among acute heart failure patients with ACE inhibitor therapy (Dr. Soetomo Regional General Hospital, Surabaya)
  24. The correlation between self-related adherence, asthma-related quality of life and control of asthma in adult patients
  25. Providing counseling through home pharmacy care (HPC) for hemodialysis patients with hypertension in lowering blood pressure
  26. Community knowledge and attitude in recognizing asthma symptoms and using medication for asthma attacks: a cross-sectional study
  27. A study of anticoagulant therapy in patients with coronary artery disease
  28. The association of FKBP5 polymorphism with asthma susceptibility in asthmatic patients
  29. Gastroprotective effect of fluvoxamine and ondansetron on stress-induced gastric ulcers in mice
  30. Osteoblast iron genes: real time PCR and microarray hybridization approach under hyperoxia
  31. Attenuation of hyperplasia in lung parenchymal and colonic epithelial cells in DMBA-induced cancer by administering Andrographis paniculata Nees extract using animal model
  32. N-nitrosodiethylamine induces inflammation of liver in mice
  33. AST/ALT levels, MDA, and liver histopathology of Echinometra mathaei ethanol extract on paracetamol-induced hepatotoxicity in rats
  34. Development, characterization, molecular docking, and in vivo skin penetration of coenzyme Q10 nanostructured lipid carriers using tristearin and stearyl alcohol for dermal delivery
  35. The effect of Camellia sinensis (green tea) with its active compound EGCG on neuronal cell necroptosis in Rattus norvegicus middle cerebral artery occlusion (MCAO) model
  36. Hepatoprotective effect of ethanolic extract of sugarcane (Saccharum officinarum Linn.) leaves
  37. Correlation between the exposure time to mobile devices and the prevalence of evaporative dry eyes as one of the symptoms of computer vision syndrome among Senior High School students in East Java, Indonesia
  38. The effect of various high-fat diet on liver histology in the development of NAFLD models in mice
  39. Fabrication and characterization of bovine hydroxyapatite-gelatin-alendronate scaffold cross-linked by glutaraldehyde for bone regeneration
  40. Health related quality of life among postmenopausal woman with hormone responsive HER2− breast cancer in Indonesia
  41. Gender differences in the blood glucose type 2 diabetes patients with combination rapid and long acting insulin therapy
  42. Correlation of dietary iron intake and serum iron with thyroid stimulating hormone (TSH) and free thyroxine (FT4) levels in adult hyperthyroid patients
  43. The effect of pillbox use and education by pharmacist toward medication adherence in diabetes mellitus patients in a Primary Health Care Center in Mataram
  44. Variation concentration effect of propyleneglycol, glycerin, and polyethyleneglycol 400 to physical properties and dissolution rate of loratadine liquisolid tablet
  45. Role of Centella asiatica and ceramide in skin barrier improvement: a double blind clinical trial of Indonesian batik workers
  46. Secondary metabolite and antipyretic effects of Maja (Crescentia cujete L.) in fever-induced mice
  47. Hydration effect on kidney function and serum electrolyte in children with tumor lysis syndrome (TLS) and risk of TLS
  48. Drug utilization study and cost analysis of adult β-thalassemia major patient therapy at Dr. Soetomo General Hospital Surabaya
  49. The role of hyperbaric oxygen to platelet aggregation in noninsulin-dependent diabetes mellitus (NIDDM)
  50. Cocrystal formation of loratadine-succinic acid and its improved solubility
  51. The role of chondroitin sulfate to bone healing indicators and compressive strength
  52. The effects of quercetin on the expression of SREBP-1c mRNA in high-fat diet-induced NAFLD in mice
  53. Analysis of stress ulcer prophylaxis drug regimentation in surgical patients
  54. The stability and irritability study of the chitosan–Aloe vera spray gel as wound healing
  55. Effectiveness of citicoline in pediatric patients with refractive amblyopia in Surabaya, East Java, Indonesia
  56. The thermodynamic study of p-methoxycinnamic acid inclusion complex formation, using β-cyclodextrin and hydroxypropyl-β-cyclodextrin
  57. The effect of chitosan type and drug-chitosan ratio on physical characteristics and release profile of ketoprofen microparticles prepared by spray drying
  58. The maximum dose and duration in the therapy single use methotrexate to achieve remission by rheumatoid arthritis patients through disease activity score 28 (DAS28)
  59. Knowledge, attitudes, and practices (KAP) towards COVID-19 among university students in Pakistan: a cross-sectional study
  60. The impact of glutaraldehyde on the characteristics of bovine hydroxyapatite-gelatin based bone scaffold as gentamicin delivery system
  61. Analysis of the use of antibiotics profile and factors of surgical site infections study on digestive and oncology surgeries
  62. Second internal transcribed spacer (ITS-2) as genetic marker for molecular characterization of Sarcoptes scabiei in rabbits from several areas of East Java, Indonesia
  63. Design of gossypetin derivatives based on naturally occurring flavonoid in Hibiscus sabdariffa and the molecular docking as antibacterial agents
  64. Discovery of new targeting agents against GAPDH receptor for antituberculosis drug delivery
  65. The effect of red passion fruit (Passiflora edulis Sims.) fermentation time on its activity against Extended Strain Methicillin-Resistant (ESBL) Escherichia coli and Methicillin-Resistant Staphylococcus aureus (MRSA)
  66. Antibiotic use on acute respiratory tract infection nonpneumonia and nonspecific diarrhea in Primary Health Care Centre in Banjarbaru City, South Kalimantan, Indonesia
  67. Screening of anti-HIV activities in ethanol extract and fractions from Ficus fistulosa leaves
  68. The characteristics of lactic acid bacteria isolated from fermented food as potential probiotics
  69. Profile of gyrA gene mutation in clinical isolate of levofloxacin resistant Escherichia coli
  70. Antimicrobial activity of Centella asiatica and Gigantochloa apus
  71. Drug-related problems of antibiotic use in gastroenteritis related to patient therapy outcomes at Universitas Gadjah Mada Hospital
  72. The impact of suitability of empirical antibiotics use on therapeutic outcome of respiratory tract infection patients at inpatient wards of Universitas Gadjah Mada Academic Hospital
  73. Genetic profile mutation rpoB in clinical isolate of rifampicin-resistant Staphylococcus aureus
  74. Hematological side effect analysis of linezolid in MDR-TB patients with individual therapy
  75. Adverse drug reaction and its management in tuberculosis patients with multidrug resistance: a retrospective study
  76. Analysis of prophylactic antibiotic use and risk factor of postoperative infection in urological surgery patients
  77. Molecular docking studies of Nigella sativa L and Curcuma xanthorrhiza Roxb secondary metabolites against histamine N-methyltransferase with their ADMET prediction
  78. Prediction of compounds with antiosteoporosis activity in Chrysophyllum cainito L. leaves through in silico approach
  79. Phyllanthin and hypophyllanthin, the isolated compounds of Phyllanthus niruri inhibit protein receptor of corona virus (COVID-19) through in silico approach
  80. Cratoxylum sumatranum stem bark exhibited antimalarial activity by Lactate Dehydrogenase (LDH) assay
  81. Endophytic fungi inhabiting Physalis angulata L. plant: diversity, antioxidant, and antibacterial activities of their ethyl acetate extracts
  82. Exploration of several plants from Baung Forest on bone formation cell models
  83. In vitro antimalarial activity of Garcinia parvifolia Miq. Stem extracts and fractions on Plasmodium falciparum lactate dehydrogenase (LDH) assay
  84. Antioxidant and antiviral potency of Begonia medicinalis fractions
  85. Artocarpus sericicarpus stem bark contains antimalarial substances against Plasmodium falciparum
  86. Formulation and characterization of Eleutherine palmifolia extract-loaded self-nanoemulsifying drug delivery system (SNEDDS)
  87. Analytical method for the determination of curcumin entrapped in polymeric micellar powder using HPLC
  88. Challenges in the provision of natural medicines by community pharmacists in East Java Province, Indonesia
  89. In vitro and in silico analysis of phytochemical compounds of 96% ethanol extract of semanggi (Marsilea crenata Presl.) leaves as a bone formation agent
  90. Inhibitory activity of Urena lobata leaf extract on alpha-amylase and alpha-glucosidase: in vitro and in silico approach
  91. Case Report
  92. Effect of hydrocortisone on hypocorticolism caused by pituitary adenoma
Downloaded on 21.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2020-0502/html
Scroll to top button